Search

everythinglearnresearchcommunity

for

Search:↓

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Live imaging helps us understand skin immune responses and develop treatments.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

B cells can both help and hinder the body's defense against melanoma.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

A patient with lupus experienced a condition where their immune cells became overactive.

Intralesional triamcinolone acetonide is preferred for treating patchy alopecia areata due to fewer side effects.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Individualized homeopathic treatment with Lycopodium clavatum may help manage alopecia areata and improve related emotional symptoms.

A tailored treatment improved a Pomeranian dog's skin and hair issues caused by a vaccine.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

IL-18 signaling helps mature Tregs move into the thymus.

Blocking LFA-1 prevents hair loss in mice.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Removing the liver tumor improved the patient's skin condition and hair growth.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

ILC1 cells contribute to hair loss in alopecia areata.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.